Showing 14,721 - 14,740 results of 21,342 for search '(( significantly ((mean decrease) OR (a decrease)) ) OR ( significant decrease decrease ))', query time: 0.38s Refine Results
  1. 14721

    Data Sheet 2_Circulating CD8 T cells from patients with mild-to-moderate psoriasis are functionally impaired.docx by Yiqiao Chen (16964252)

    Published 2025
    “…</p>Conclusion<p>Patients with mild-to-moderate psoriasis showed a significant decrease in CD8 T memory cells and reduced release of cytotoxic mediators by CD8 T cells. …”
  2. 14722

    Table 1_Enhancement of prefrontal functional connectivity under the influence of concurrent physical load during mental tasks.docx by Shan Cheng (1569355)

    Published 2024
    “…</p>Results<p>On the basis of effects of cognitive tasks, the concurrent physical activities would further increase National Aeronautics and Space Administration Task Load Index score (p < 0.05) and decrease task performance (p < 0.05). The fNIRS-based results showed that cognitive and physical loads had significant interaction effects on CORR (p < 0.05), COH (p < 0.05), and PLV (p = 0.010), while their main effects were not significant. …”
  3. 14723

    Presentation1_Unraveling cell wall polysaccharides during blueberry ripening: insights into the roles of rhamnogalacturonan-I and arabinogalactan proteins in fruit firmness.pdf by Dayan Sanhueza (4752282)

    Published 2024
    “…<p>Blueberries (Vaccinium corymbosum) undergo significant texture changes during development and ripening, notably a consistent decrease in firmness, which affects fruit quality, consumer preference, transportability, and shelf life. …”
  4. 14724

    DTG 3TC HIV EPI study.xlsx by Anna Esman (17983927)

    Published 2024
    “…Using both Sanger sequencing and pyrosequencing methods, we examined 51 biological samples from 17 HIV-1-infected individuals at three time points: baseline (Week 0) and post-antiretroviral therapy (ART) at Weeks 24 and 48.Our results revealed that <i>CXCR4</i> promoter CpG sites were largely unmethylated, while <i>CCR5</i> promoter CpGs exhibited significant variability in methylation levels. Specifically, <i>CCR5</i> CpG 1 showed a significant increase in methylation from Week 0 to Week 48, while <i>CXCR4</i> CpG 3 displayed a significant decrease between Week 0 and Week 24. …”
  5. 14725

    Quantification of GFP::2xFLAG::SEM-2 expression during M lineage development. by Marissa Baccas (20592105)

    Published 2025
    “…To prevent the graph from being too crowded, only <i>P</i> values not shown in panels A-F are shown in G-I. There is a gradual decrease in the level of nuclear GFP::2xFLAG::SEM-2 in the early M lineage after the 2-M stage (A). …”
  6. 14726

    Table 1_Molecular hybridization modification improves the stability and immunomodulatory activity of TP5 peptide.docx by Junyong Wang (3807964)

    Published 2024
    “…<p>Thymopentin (TP5) plays an important role in host immunomodulation, yet its bioavailability is significantly limited by its short half-life. YW12D is a peptide with strong stability but relatively weak immunoactivity. …”
  7. 14727

    Data Sheet 1_Analysis between Helicobacter pylori infection and hepatobiliary diseases.docx by Zhenjun Yu (8205228)

    Published 2025
    “…Compared to the non-infection group, patients in the infection group exhibited a significant decrease in albumin levels and a notable increase in total cholesterol and erythrocyte sedimentation rate levels. …”
  8. 14728

    Joint and muscle-tendon coordination strategies during submaximal jumping (dataset) by L Wade (13546942)

    Published 2025
    “…Alternatively, hip joint work was significantly increased as a result of altered muscle activation strategies, likely possible due to a substantially greater activation period compared to plantar flexor muscles during jumping. …”
  9. 14729

    First Sila-Vitamin D Analogues: Design, Synthesis, Structural Analysis and Biological Activity by Julian Loureiro (20357035)

    Published 2024
    “…These sila-analogues show similar VDR binding and transcriptional activity in comparison with the natural hormone 1,25D<sub>3</sub>, but with significantly less hypercalcemic activity. The new analogues, when combined with chemotherapy, significantly decrease cell proliferation.…”
  10. 14730

    First Sila-Vitamin D Analogues: Design, Synthesis, Structural Analysis and Biological Activity by Julian Loureiro (20357035)

    Published 2024
    “…These sila-analogues show similar VDR binding and transcriptional activity in comparison with the natural hormone 1,25D<sub>3</sub>, but with significantly less hypercalcemic activity. The new analogues, when combined with chemotherapy, significantly decrease cell proliferation.…”
  11. 14731

    First Sila-Vitamin D Analogues: Design, Synthesis, Structural Analysis and Biological Activity by Julian Loureiro (20357035)

    Published 2024
    “…These sila-analogues show similar VDR binding and transcriptional activity in comparison with the natural hormone 1,25D<sub>3</sub>, but with significantly less hypercalcemic activity. The new analogues, when combined with chemotherapy, significantly decrease cell proliferation.…”
  12. 14732

    First Sila-Vitamin D Analogues: Design, Synthesis, Structural Analysis and Biological Activity by Julian Loureiro (20357035)

    Published 2024
    “…These sila-analogues show similar VDR binding and transcriptional activity in comparison with the natural hormone 1,25D<sub>3</sub>, but with significantly less hypercalcemic activity. The new analogues, when combined with chemotherapy, significantly decrease cell proliferation.…”
  13. 14733

    First Sila-Vitamin D Analogues: Design, Synthesis, Structural Analysis and Biological Activity by Julian Loureiro (20357035)

    Published 2024
    “…These sila-analogues show similar VDR binding and transcriptional activity in comparison with the natural hormone 1,25D<sub>3</sub>, but with significantly less hypercalcemic activity. The new analogues, when combined with chemotherapy, significantly decrease cell proliferation.…”
  14. 14734

    First Sila-Vitamin D Analogues: Design, Synthesis, Structural Analysis and Biological Activity by Julian Loureiro (20357035)

    Published 2024
    “…These sila-analogues show similar VDR binding and transcriptional activity in comparison with the natural hormone 1,25D<sub>3</sub>, but with significantly less hypercalcemic activity. The new analogues, when combined with chemotherapy, significantly decrease cell proliferation.…”
  15. 14735

    First Sila-Vitamin D Analogues: Design, Synthesis, Structural Analysis and Biological Activity by Julian Loureiro (20357035)

    Published 2024
    “…These sila-analogues show similar VDR binding and transcriptional activity in comparison with the natural hormone 1,25D<sub>3</sub>, but with significantly less hypercalcemic activity. The new analogues, when combined with chemotherapy, significantly decrease cell proliferation.…”
  16. 14736

    First Sila-Vitamin D Analogues: Design, Synthesis, Structural Analysis and Biological Activity by Julian Loureiro (20357035)

    Published 2024
    “…These sila-analogues show similar VDR binding and transcriptional activity in comparison with the natural hormone 1,25D<sub>3</sub>, but with significantly less hypercalcemic activity. The new analogues, when combined with chemotherapy, significantly decrease cell proliferation.…”
  17. 14737

    First Sila-Vitamin D Analogues: Design, Synthesis, Structural Analysis and Biological Activity by Julian Loureiro (20357035)

    Published 2024
    “…These sila-analogues show similar VDR binding and transcriptional activity in comparison with the natural hormone 1,25D<sub>3</sub>, but with significantly less hypercalcemic activity. The new analogues, when combined with chemotherapy, significantly decrease cell proliferation.…”
  18. 14738

    First Sila-Vitamin D Analogues: Design, Synthesis, Structural Analysis and Biological Activity by Julian Loureiro (20357035)

    Published 2024
    “…These sila-analogues show similar VDR binding and transcriptional activity in comparison with the natural hormone 1,25D<sub>3</sub>, but with significantly less hypercalcemic activity. The new analogues, when combined with chemotherapy, significantly decrease cell proliferation.…”
  19. 14739

    First Sila-Vitamin D Analogues: Design, Synthesis, Structural Analysis and Biological Activity by Julian Loureiro (20357035)

    Published 2024
    “…These sila-analogues show similar VDR binding and transcriptional activity in comparison with the natural hormone 1,25D<sub>3</sub>, but with significantly less hypercalcemic activity. The new analogues, when combined with chemotherapy, significantly decrease cell proliferation.…”
  20. 14740

    First Sila-Vitamin D Analogues: Design, Synthesis, Structural Analysis and Biological Activity by Julian Loureiro (20357035)

    Published 2024
    “…These sila-analogues show similar VDR binding and transcriptional activity in comparison with the natural hormone 1,25D<sub>3</sub>, but with significantly less hypercalcemic activity. The new analogues, when combined with chemotherapy, significantly decrease cell proliferation.…”